The transgenic construct contains a mouse vav 1 oncogene promoter/control regions directing expression of a wildtype (catalytically-active) human eukaryotic translation initiation factor 2-alpha kinase 2 cDNA sequence (EIF2AK2). Three transgenic (TgPKR) founder lines were generated; all displaying the same phenotype and were used interchangeably. (J:196300)